tiprankstipranks
Trending News
More News >
SynAct Pharma AB (DE:8F8)
FRANKFURT:8F8
Germany Market

SynAct Pharma AB (8F8) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
11Bullish
0Neutral
2Bearish
Technical Analysis Consensus
Strong Buy
1Bullish
0Neutral
0Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
SynAct Pharma AB’s (8F8) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting SynAct Pharma AB is a Buy.
SynAct Pharma AB’s (8F8) 20-Day exponential moving average is 1.47, while SynAct Pharma AB’s (8F8) share price is €1.45, making it a Buy.
SynAct Pharma AB’s (8F8) 50-Day exponential moving average is 1.37, while SynAct Pharma AB’s (8F8) share price is €1.45, making it a Buy.

SynAct Pharma AB (8F8) Pivot Points

Apr 08, 2025, 10:02 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.31
1.35
1.38
1.42
1.45
1.49
1.52
Fibonacci
1.35
1.37
1.39
1.42
1.44
1.46
1.49
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SynAct Pharma AB (8F8) Moving Averages

Apr 08, 2025, 10:02 PM
Period
Simple
Exponential
MA5
1.54Sell
1.54Sell
MA10
1.47Buy
1.50Buy
MA20
1.45Buy
1.47Buy
MA50
1.41Buy
1.37Buy
MA100
1.13Buy
1.20Buy
MA200
0.93Buy
1.00Buy
SynAct Pharma AB’s (8F8) 10-Day exponential moving average is 1.50, while SynAct Pharma AB’s (8F8) share price is €1.45, making it a Buy.
SynAct Pharma AB’s (8F8) 100-Day exponential moving average is 1.20, while SynAct Pharma AB’s (8F8) share price is €1.45, making it a Buy.
SynAct Pharma AB’s (8F8) stock price is €1.45 and SynAct Pharma AB’s (8F8) 50-day simple moving average is 1.41, creating a Buy signal.
SynAct Pharma AB’s (8F8) stock price is €1.45 and SynAct Pharma AB’s (8F8) 100-day simple moving average is 1.13, creating a Buy signal.
SynAct Pharma AB’s (8F8) stock price is €1.45 and SynAct Pharma AB’s (8F8) 200-day simple moving average is 0.93, creating a Buy signal.

SynAct Pharma AB (8F8) Technical Indicators

Apr 08, 2025, 10:02 PM
Name
Value
Implied Action
RSI (14)
45.33
Neutral
STOCH (9,6)
29.89
Neutral
STOCHRSI (14)
18.87
Buy
MACD (12,26)
0.02
Buy
ADX (14)
30.06
Neutral
Williams %R
-91.67
Buy
CCI (14)
-110.15
Buy
ATR (14)
0.08
-
Ultimate Oscillator
42.35
Neutral
ROC
6.94
Buy
SynAct Pharma AB’s (8F8) Relative Strength Index (RSI) is 45.33, creating a Neutral signal.
SynAct Pharma AB’s (8F8) Trend Strength Indicator (ADX) is 30.06, creating a Neutral signal.
SynAct Pharma AB’s (8F8) Commodity Channel Index (CCI) is -110.15, creating a Buy signal.
SynAct Pharma AB’s (8F8) Price Rate of Change (ROC) is 6.94, creating a Buy signal.

FAQ

Is 8F8 a Buy, Hold, or Sell?
Based on 8F8’s technical indicators, 8F8 is a Strong Buy.
    What is 8F8’s RSI (14)?
    8F8’s RSI (14) is 45.33, which suggests 8F8 is a Neutral.
      What is 8F8’s MACD?
      8F8’s MACD is 0.02, which suggests 8F8 is a Buy.
        What is 8F8’s 5-day moving average?
        8F8’s 5-day moving average is 1.54, which suggests 8F8 is a Sell.
          What is 8F8’s 20-day moving average?
          8F8 20-day moving average is 1.45, which suggests 8F8 is a Buy.
            What is 8F8’s 50-day moving average?
            8F8’s 50-day moving average is 1.41, which suggests 8F8 is a Buy.
              What is 8F8’s 200-day moving average?
              8F8’s 200-day moving average is 0.93, which suggests 8F8 is a Buy.
                What is 8F8’s Williams % R (14)?
                8F8’s Williams % R (14) is -91.67, which suggests 8F8 is a Buy.
                  What is 8F8’s CCI (14)?
                  8F8’s CCI (14) is -110.15, which suggests 8F8 is a Buy.
                    What is the share price of SynAct Pharma AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis